PSMD3 and chronic myelogenous leukemia, BCR-ABL1 positive: PSMD3 promotes nuclear factor kappa-light-chain-enhancer of activated B cells protein expression in chronic myeloid leukemia cells and, thus, promotes disease progression to a chronic state [34].